Get notified when HALO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: HALO HALOZYME THERAPEUTICS, INC. 8-K

Halozyme COO Cortney Caudill departs amid senior management restructuring

Filed July 2, 2026 · Period ending June 30, 2026 · ~1 min read

Key Changes

  • medium

    COO Cortney Caudill departed June 30, 2026 as part of a senior management restructuring. No transition details or replacement announced.

    Item 5.02 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (STZ 10-Q) is open in full — no account needed.

Partner

Trade HALO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Source-verified from EDGAR · Narrative written by AI · Jul 8, 2026 · How we verify